ABECMA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 17 Mar 2026)
What this means for you
Registered since 14 Jan 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88202247
- Registration number
- 5958800
- Mark type
- Stylized text
- Filed
- 21 Nov 2018
- Published for opposition
- 29 Oct 2019
- Registered
- 14 Jan 2020
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment of multiple myeloma, blood disease, cancer, diseases in the fields of oncology, immunology and [ inflammation ] ; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
Owner
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, Summit, NJ, US
Prosecution history
- 17 Mar 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 17 Mar 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 16 Mar 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Dec 2025 — TEAS SECTION 8 & 15 RECEIVED
- 14 Jan 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Dec 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 09 Dec 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Dec 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 09 Dec 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Dec 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Dec 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 14 Jan 2020 — REGISTERED-PRINCIPAL REGISTER
- 29 Oct 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Oct 2019 — PUBLISHED FOR OPPOSITION
- 09 Oct 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED